Not one, but three, antimelanoma vaccines are showing promising results in clinical trials, according to data presented at the International Conference on Melanoma in Brisbane, Australia [April 1994]. This week,Inpharmatakes a look at the two antigenic vaccines in development, one in the US and one in Australia, and considers whether increased antigenicity is the key to success.